Atlas Bio leaves stealth with $12.5M to test drugs on simulated patients
The Swiss startup built a foundation model on two million tissue RNA readouts and wants it to stand in for…
Trending Now
Robinhood Ventures Fund II brings retail capital to healthcare AI
The NYSE-listed BDC devotes about 6.7% of assets to early-stage healthcare AI, from cancer screening to clinic operations.
Brain implant decoders fail when patients or hardware change, review warns
A new review argues that brain-computer interfaces should be judged on whether…
Proteomics model picks breast cancer drugs from biopsies
A virtual-cell model trained on 38 million protein measurements matched real treatment…
Stanford Health AI Week Highlights AI’s Growing Role in Medical Education, Patient Empowerment, and Life Sciences
Stanford Medicine's weeklong Health AI event across eight symposia explored how AI is empowering patients, reshaping medical education, accelerating cancer…
AI Emerges as a Game-Changer in Humanitarian Healthcare Crisis Response
AI is being harnessed to transform humanitarian healthcare, improving disaster response, disease surveillance, mental health…
HKUST Pioneers Micro-Robotics and AI Tools to Reshape Global Healthcare
From ultra-miniature surgical robots to gamified respiratory monitors, HKUST is redefining medical technology with innovations…
High-Quality Data Is Key to Unlocking AI’s Full Potential in Clinical Trials
AI is streamlining clinical trials and cutting drug development costs, but success hinges on data…
Sanofi India will mentor and may fund AI heart startup Tricog
Sanofi India signed a letter of intent that could bring three years of mentoring, market…
New Zealand health system partners with NHS for AI scribe rollout
Te Whatu Ora partners with UCLPartners to gain evidence and confidence for AI scribe deployment…
Google SymptomAI outperforms doctors in real-world symptom interviews
Google Research shows its conversational AI agent beats clinicians in diagnostic accuracy during a national-scale…
Boehringer bets up to $1B on RNA splicing targets from Envisagenics
The New York company will mine alternative splicing for tumor-specific targets that drug makers can…
ECG-only AI predicts significant coronary blockages before scans
An AI trained on ECGs identifies vessel-specific coronary blockages and improves risk reclassification before imaging.
AI rivals expert radiologists at fetal brain fluid ultrasound
A deep learning model measured fetal ventricular width across more than a thousand pregnancies, reaching…
Astellas pays over $400M up front for proteins built from scratch
Astellas is handing AI Proteins a large upfront check to design miniprotein drugs that no…
AstraZeneca taps AI to de-risk late-stage trials and speed up filings
AstraZeneca CEO Pascal Soriot said the company is using AI to de-risk late-stage clinical trials…